UnitedHealth 2018 Formulary Updates Broaden Exclusions, Deter Copay Coupons
Executive Summary
Insurer will begin excluding drugs when there are less expensive and clinically equivalent alternatives available and eliminate manufacturer coupons from the calculation of deductibles and out-of-pocket limits.
You may also be interested in...
Payers' Latest Attack On Copay Coupons: 'Accumulator' Programs
More payers are implementing programs that block manufacturer copay coupons for specialty drugs from being applied to deductibles and out-of-pocket maximums, exposing members to higher drug costs.
Payers Could Guarantee Biosimilar Market Share, FDA's Gottlieb Suggests
Commissioner worries that fewer drugs may enter market in some categories because of drug development costs, and offers some post-market strategies for encouraging biosimilar development.
Teva's AirDuo Authorized Generic Priced At A 70% Discount To Advair
Teva's decision to launch an authorized generic version of AirDuo, a drug made up of the same active ingredients in GSK's Advair, at a steep discount to typical brand drugs for asthma will help encourage use, even though it is not interchangeable.